You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DESTINY-BREAST11

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DESTINY Breast Respond HER2-low Europe

Not yet recruiting
  • Unresectable Breast Cancer
  • +2 more
  • Trastuzumab deruxtecan
  • (no location specified)
Jul 6, 2023

Breast Cancer Trial (Trastuzumab Deruxtecan)

Not yet recruiting
  • Breast Cancer
  • Trastuzumab Deruxtecan
  • (no location specified)
Jul 10, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +6 more
  • Iowa City, Iowa
  • +60 more
Jan 3, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Lobular Carcinoma, Metastatic Breast Lobular Carcinoma Trial in Atlanta

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Computed Tomography
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Aug 9, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +4 more
  • West Hollywood, California
  • +101 more
Jan 16, 2023

ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

Recruiting
  • ER+ Breast Cancer
  • 4FMFES-PET
  • Sherbrooke, Quebec, Canada
    Université deSherbrooke
Jul 18, 2022

Breast Cancer, Breast Tumors, HER2-positive Breast Cancer Trial in Guanzhou (HLX11, EU-Perjeta®)

Recruiting
  • Breast Cancer
  • +2 more
  • Guanzhou, Guangdong, China
    Sun Yat-Sun Yat-sen Hospital affiliated to Sun Yat-sen Universit
Apr 28, 2022

Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Fairfax, Virginia
    NEXT Oncology
Jun 7, 2023

Breast Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Los Angeles (Computed Tomography, Gallium Ga 68 FAPi-46,

Recruiting
  • Breast Carcinoma
  • +10 more
  • Computed Tomography
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Nov 29, 2022

Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Oak Lawn, Houston (Best Practice, Ixabepilone)

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +2 more
  • Oak Lawn, Illinois
  • +2 more
Mar 10, 2022

Alzheimer Trial in Leuven, Wilrijk (11C-JNJ-63779586)

Completed
  • Alzheimer Disease
  • Leuven, Belgium
  • +1 more
Dec 7, 2021

Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

Recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +10 more
Nov 11, 2022

ER-positive, HER2-negative Breast Cancer Trial in Ruddington ([14C]AZD9833 Oral Solution, 75 mg)

Completed
  • ER-positive, HER2-negative Breast Cancer
  • [14C]AZD9833 Oral Solution, 75 mg
  • Ruddington, United Kingdom
    Research Site
Jun 24, 2022

Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Los Angeles, California
  • +4 more
Jul 19, 2022

Factors Influencing Cascade Testing Among Hereditary

Recruiting
  • Breast Carcinoma
  • +8 more
  • Interview
  • +2 more
  • Birmingham, Alabama
  • +1 more
Jun 22, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

RWE About QOL and Compliance of Patients With OFS in China

Not yet recruiting
  • Breast Cancer
  • +2 more
  • 3M GnRHa
  • 1M GnRHa
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 15, 2021

HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer Trial in Worldwide (DS-8201a, T-DM1)

Recruiting
  • HER2-Positive Primary Breast Cancer
  • Residual Invasive Breast Cancer
  • Anaheim, California
  • +505 more
Feb 2, 2023

Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)

Active, not recruiting
  • Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Nov 15, 2023

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Milk on the Neurodevelopment of Preterm Newborns

Active, not recruiting
  • Prematurity of Fetus
  • Physiopathology
  • Nantes, France
    University Hospital of Nantes
Jul 20, 2021

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022